Yumanity Therapeutics Inc Virtual Investor R&D Day Transcript
Good day, and thank you for standing by. Welcome to the Yumanity Therapeutics R&D day conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Paulash Mohsen, Chief Business Officer of Yumanity Therapeutics. Please go ahead.
Good day, everyone. I'm Paulash Mohsen, Chief Business Officer of Yumanity Therapeutics. It's my pleasure to welcome you to Yumanity's first R&D Day. During the course of today's presentation, we will be making certain forward-looking statements and therefore, refer you to the risk factors detailed in our recent annual and quarterly SEC filings.
The agenda for this 90 minute session is shown on Page 3. We will begin with an introduction to the company by our CEO, Richard Peters, followed by an outlook on the field of neurodegeneration by our new Head of R&D, Ajay Verma. We are pleased to host Dr. David Russell from the Yale School of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |